BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 30910388)

  • 1. Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Yamamoto M; Hamada-Harimura Y; Machino T; Yamasaki H; Sekiguchi Y; Nogami A; Aonuma K; Ieda M
    J Cardiol; 2019 Sep; 74(3):235-244. PubMed ID: 30910388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction.
    Sartipy U; Savarese G; Dahlström U; Fu M; Lund LH
    Eur J Heart Fail; 2019 Apr; 21(4):471-479. PubMed ID: 30698317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: The RAFT-AF trial rationale and design.
    Parkash R; Wells G; Rouleau J; Talajic M; Essebag V; Skanes A; Wilton SB; Verma A; Healey JS; Tang AS
    Am Heart J; 2021 Apr; 234():90-100. PubMed ID: 33472052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction.
    Fukui A; Tanino T; Yamaguchi T; Hirota K; Saito S; Okada N; Akioka H; Shinohara T; Yufu K; Takahashi N
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):682-688. PubMed ID: 31985099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community-based study.
    Zhang P; Chamberlain AM; Hodge DO; Cai C; Xiao PL; Han J; Jiang CY; Redfield MM; Roger VL; Cha YM
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2275-2283. PubMed ID: 32584498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
    Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
    Zafrir B; Lund LH; Laroche C; Ruschitzka F; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Seferovic PM; Maggioni AP; De Mora Martin M; Polonski L; Silva-Cardoso J; Amir O;
    Eur Heart J; 2018 Dec; 39(48):4277-4284. PubMed ID: 30325423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas Trial.
    Saksena S; Slee A; Natale A; Lakkireddy DR; Shah D; Di Biase L; Lewalter T; Nagarakanti R; Santangeli P
    Europace; 2023 May; 25(5):. PubMed ID: 37078691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2020 May; 36(5):921-928. PubMed ID: 32030576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status - Report From the Japanese Nationwide Multicenter Registry.
    Temma T; Nagai T; Watanabe M; Kamada R; Takahashi Y; Hagiwara H; Koya T; Nakao M; Omote K; Kamiya K; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
    Circ J; 2020 Feb; 84(3):397-403. PubMed ID: 32009066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction.
    Xie Z; Qi B; Wang Z; Li F; Chen C; Li C; Yuan S; Yao S; Zhou J; Ge J
    Europace; 2023 Dec; 26(1):. PubMed ID: 38099508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study.
    Zakeri R; Chamberlain AM; Roger VL; Redfield MM
    Circulation; 2013 Sep; 128(10):1085-93. PubMed ID: 23908348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation for atrial fibrillation in HFpEF patients-A propensity-score-matched analysis.
    Rattka M; Kühberger A; Pott A; Stephan T; Weinmann K; Baumhardt M; Aktolga D; Teumer Y; Bothner C; Scharnbeck D; Rottbauer W; Dahme T
    J Cardiovasc Electrophysiol; 2021 Sep; 32(9):2357-2367. PubMed ID: 34379370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
    Oraii A; McIntyre WF; Parkash R; Kowalik K; Razeghi G; Benz AP; Belley-Côté EP; Conen D; Connolly SJ; Tang ASL; Healey JS; Wong JA
    JAMA Cardiol; 2024 Jun; 9(6):545-555. PubMed ID: 38656292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure.
    Ichijo S; Miyazaki S; Kusa S; Nakamura H; Hachiya H; Kajiyama T; Iesaka Y
    J Cardiol; 2018 Sep; 72(3):240-246. PubMed ID: 29609877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate and outcomes in patients with heart failure with preserved ejection fraction: A dose-response meta-analysis.
    Shang X; Lu R; Liu M; Xiao S; Dong N
    Medicine (Baltimore); 2017 Oct; 96(43):e8431. PubMed ID: 29069045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.